FDA Inspection
Dr. Louis R. ManaraDr. Louis R. Manara – FDA Inspection, May 23, 2023
Record Details
This FDA Inspection record concerns Dr. Louis R. Manara, with an inspection on May 23, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · cc9aef08-c3bc-42ad-9fe9-a2851d77a79f
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1206226
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 1271.75(d)Donors with risks not determined ineligible
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Dr. Louis R. Manara
8| Date | Classification | Office | Project area |
|---|---|---|---|
| March 26, 2024 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| October 21, 2021 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| January 28, 2020 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| January 12, 2018 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| August 18, 2016 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Dr. Louis R. Manara
- FDA Inspection 1236701 - 2024-03-26
- FDA Inspection 1152479 - 2021-10-21
- FDA Inspection 1116668 - 2020-01-28
- FDA Inspection 1039896 - 2018-01-12
- FDA Inspection 982516 - 2016-08-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.